Güvenç, Furkan2023-11-172023-11-172018Bal, S. H. vd. (2018). ''Effect of storage period of red blood cell suspensions on helper T-cell subpopulations''. Blood Transfusion, 16(3), 262-272.1723-2007https://doi.org/10.2450/2017.0238-16https://www.bloodtransfusion.it/bt/article/view/323http://hdl.handle.net/11452/34939Background. The aim of this study was to investigate the immunological alterations that occur during the storage of erythrocyte suspensions which may lead to transfusion-related immunomodulation following allogeneic blood transfusion. Materials and methods. One part of the erythrocyte suspensions obtained from donors was leucoreduced while the other part was not. The leucoreduced (LR) and non-leucoreduced (NL) erythrocyte suspensions were then further divided into three equal amounts which were stored for 0, 21 or 42 days prior to measurements, by enzyme-linked immunosorbent assays, of cytokine levels in their supernatants. T-helper (Th) lymphocyte subgroups and gene expression were analysed in the NL erythrocyte suspensions by flow cytometry and real-time polymerase chain reaction, respectively. Results were compared to those of storage day 0. Results. By day 21, the number of Th2 cells had increased significantly and the numbers of Th1, Th22 and Treg cells had decreased significantly in the NL erythrocyte suspensions. On day 42 the numbers of Th2 and Treg cells in the NL suspensions were significantly increased while the number of Th1 cells was significantly decreased. The levels of transcription factors (TBX21, GATA3, and SPI.1) were significantly decreased on days 21 and 42, and AHR, FOXP3 and RORC2 levels were significantly increased on day 42 in NL erythrocyte suspensions. The decrease in interleukin-22 and increase in transforming growth factor-beta levels found in NL erythrocyte suspensions on day 21 were statistically significant. Elevated levels of interleukin-17A were found in both LR and NL erythrocyte suspensions on day 42. Discussion. Our results suggest that allogeneic leucocytes and cytokines may play significant roles in the development of transfusion-related immunomodulation.eninfo:eu-repo/semantics/closedAccessHematologyTRIMImmunomodulationTransfusionTh cell subgroupsLeucoreductionRandomized controlled-trialTransfusion-related immunomodulationColorectal-cancer surgeryIndependent risk-factorGrowth-factor-betaAcute lung injuryCardiac-surgeryWhole-bloodPostoperative infectionLeukocyte depletionAntigens, differentiationBlood preservationErythrocytesFemaleHumansInterleukinsMaleT-Lymphocytes, helper-inducerArticle0004307215000072-s2.0-8504615505326227216328488961HematologyBlood Transfusion; Cystectomy; OutcomeAhr proteinInterleukin 17Interleukin 22ProteinRorc2 proteinTranscription factor FOXP3Transcription factor GATA 3Transcription factor Sp1Transcription factor T betTransforming growth factor betaUnclassified drugDifferentiation antigenInterleukin derivativeInterleukin-22ArticleBlood donorBlood storageCell suspensionControlled studyEnzyme linked immunosorbent assayErythrocyte transfusionFlow cytometryGene expressionHumanHuman cellImmunomodulationReal time polymerase chain reactionRegulatory T lymphocyteSupernatantT lymphocyte subpopulationTh2 cellTh22 cellCytologyErythrocyteFemaleHelper cellImmunologyMale